HORIZON PHARMA INVT LTD's ticker is and the CUSIP is 44052TAB7. A total of 28 filers reported holding HORIZON PHARMA INVT LTD in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $13,068,000 | -3.6% | 11,282,000 | +9.4% | 0.01% | +25.0% |
| Q4 2019 | $13,553,000 | -19.5% | 10,313,000 | -28.1% | 0.00% | -20.0% |
| Q3 2019 | $16,835,000 | +96.5% | 14,353,000 | +85.7% | 0.01% | +150.0% |
| Q2 2019 | $8,568,000 | -43.8% | 7,729,000 | -42.5% | 0.00% | -60.0% |
| Q1 2019 | $15,232,000 | +285.8% | 13,444,000 | +239.5% | 0.01% | +400.0% |
| Q4 2018 | $3,948,000 | -18.0% | 3,960,000 | -17.2% | 0.00% | 0.0% |
| Q3 2018 | $4,817,000 | +105.8% | 4,785,000 | +95.7% | 0.00% | 0.0% |
| Q2 2018 | $2,341,000 | -23.2% | 2,445,000 | -27.5% | 0.00% | 0.0% |
| Q2 2016 | $3,050,000 | -73.3% | 3,371,000 | -74.8% | 0.00% | -80.0% |
| Q1 2016 | $11,408,000 | – | 13,399,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|